PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23349882-5	2013	RESULTS: During interferon beta (IFNB) treatment, each 10 micromol/L increase in alpha-tocopherol reduced the odds (CI 95%) for simultaneous new T2 lesions by 36.8 (0.5-59.8) %, p = 0.048, and for combined unique activity by 35.4 (1.6-57.7) %, p = 0.042, in a hierarchical regression model.	alpha-Tocopherol	81-97	interferon beta 1	Homo sapiens	16-31	
23349882-8	2013	CONCLUSION: During treatment with IFNB, increasing serum concentrations of alpha-tocopherol were associated with reduced odds for simultaneous and subsequent MRI disease activity in RRMS patients.	alpha-Tocopherol	75-91	interferon beta 1	Homo sapiens	34-38	
23349882-5	2013	RESULTS: During interferon beta (IFNB) treatment, each 10 micromol/L increase in alpha-tocopherol reduced the odds (CI 95%) for simultaneous new T2 lesions by 36.8 (0.5-59.8) %, p = 0.048, and for combined unique activity by 35.4 (1.6-57.7) %, p = 0.042, in a hierarchical regression model.	alpha-Tocopherol	81-97	interferon beta 1	Homo sapiens	33-37